ГМ2 ганглиозидозе (Serbian Wikipedia)

Analysis of information sources in references of the Wikipedia article "ГМ2 ганглиозидозе" in Serbian language version.

refsWebsite

Global rank Serbian rank

6nih.gov

4^th place

8^th place

5doi.org

2^nd place

4^th place

2semanticscholar.org

11^th place

23^rd place

2clinicaltrials.gov

5,225^th place

6,444^th place

1clinicalkey.com

low place

1fda.gov

447^th place

925^th place

1europa.eu

68^th place

107^th place

1web.archive.org

1^st place

1intrabio.com

low place

clinicalkey.com

Patterson, James W. „Metabolic and storage diseases. Weedon's Skin Pathology”. www.clinicalkey.com. Приступљено 2022-02-28.

clinicaltrials.gov

IntraBio Inc (2021-04-06). „Effects of N-Acetyl-L-Leucine on Niemann Pick Type C Disease: A Multinational, Multicenter, Open-label, Rater-blinded Phase II Study.”.
IntraBio Inc (2021-04-06). „Effects of N-Acetyl-L-Leucine on Ataxia-Telangiectasia (A-T): A Multinational, Multicenter, Open-label, Rater-blinded Phase II Study”.

doi.org

Hall, Patricia; Minnich, Sara; Teigen, Claire; Raymond, Kimiyo (октобар 2014). „Diagnosing Lysosomal Storage Disorders: The GM2 Gangliosidoses”. Current Protocols in Human Genetics. 83: 17.16.1—8. PMID 25271840. doi:10.1002/0471142905.hg1716s83. .
Maegawa, G. H.; Tropak, M.; Buttner, J.; Stockley, T.; Kok, F.; Clarke, J. T.; Mahuran, D. J. (2007-03-23). „Pyrimethamine as a potential pharmacological chaperone for late-onset forms of GM2 gangliosidosis”. J Biol Chem. 282 (12): 9150—61. PMC 1851921 . PMID 17237499. doi:10.1074/jbc.M609304200 .
Nolan, D.; Carlson, M. (јун 2016). „Whole Exome Sequencing in Pediatric Neurology Patients: Clinical Implications and Estimated Cost Analysis”. Journal of Child Neurology. 31 (7): 887—94. PMID 26863999. S2CID 206552341. doi:10.1177/0883073815627880.
Kohyama, M.; Yabuki, A.; Ochiai, K.; Nakamoto, Y.; Uchida, K.; Hasegawa, D.; Takahashi, K.; Kawaguchi, H.; Tsuboi, M.; Yamato, O. (март 2016). „In situ detection of GM1 and GM2 gangliosides using immunohistochemical and immunofluorescent techniques for auxiliary diagnosis of canine and feline gangliosidoses”. BMC Vet Res. 12: 67. PMC 4815186 . PMID 27036194. doi:10.1186/s12917-016-0691-y . .
Strupp, Michael; Bayer, Otmar; Feil, Katharina; Straube, Andreas (2019). „Prophylactic treatment of migraine with and without aura with acetyl-dl-leucine: A case series”. Journal of Neurology. 266 (2): 525—529. PMID 30547273. S2CID 56148131. doi:10.1007/s00415-018-9155-6.

europa.eu

ema.europa.eu

„orphan-designations/eu3171949”. 17. 9. 2018.

fda.gov

accessdata.fda.gov

„Search Orphan Drug Designations and Approvals”. www.accessdata.fda.gov. Приступљено 2023-02-05.

intrabio.com

„INTRABIO RECEIVES FDA RARE PEDIATRIC DISEASE DESIGNATION FOR IB1000S FOR GM2 GANGLIOSIDOSES | IntraBio” (на језику: енглески). 2018-10-01. Архивирано из оригинала 01. 08. 2019. г. Приступљено 2022-02-28.

nih.gov

ncbi.nlm.nih.gov

Hall, Patricia; Minnich, Sara; Teigen, Claire; Raymond, Kimiyo (октобар 2014). „Diagnosing Lysosomal Storage Disorders: The GM2 Gangliosidoses”. Current Protocols in Human Genetics. 83: 17.16.1—8. PMID 25271840. doi:10.1002/0471142905.hg1716s83. .
Maegawa, G. H.; Tropak, M.; Buttner, J.; Stockley, T.; Kok, F.; Clarke, J. T.; Mahuran, D. J. (2007-03-23). „Pyrimethamine as a potential pharmacological chaperone for late-onset forms of GM2 gangliosidosis”. J Biol Chem. 282 (12): 9150—61. PMC 1851921 . PMID 17237499. doi:10.1074/jbc.M609304200 .
Nolan, D.; Carlson, M. (јун 2016). „Whole Exome Sequencing in Pediatric Neurology Patients: Clinical Implications and Estimated Cost Analysis”. Journal of Child Neurology. 31 (7): 887—94. PMID 26863999. S2CID 206552341. doi:10.1177/0883073815627880.
Kohyama, M.; Yabuki, A.; Ochiai, K.; Nakamoto, Y.; Uchida, K.; Hasegawa, D.; Takahashi, K.; Kawaguchi, H.; Tsuboi, M.; Yamato, O. (март 2016). „In situ detection of GM1 and GM2 gangliosides using immunohistochemical and immunofluorescent techniques for auxiliary diagnosis of canine and feline gangliosidoses”. BMC Vet Res. 12: 67. PMC 4815186 . PMID 27036194. doi:10.1186/s12917-016-0691-y . .
Adam, M. P.; Mirzaa, G. M.; Pagon, R. A.; Wallace, S. E.; Bean LJH; Gripp, K. W.; Amemiya, A.; Toro, C.; Shirvan, L.; Tifft, C. (1993). „HEXA Disorders”. PMID 20301397.
Strupp, Michael; Bayer, Otmar; Feil, Katharina; Straube, Andreas (2019). „Prophylactic treatment of migraine with and without aura with acetyl-dl-leucine: A case series”. Journal of Neurology. 266 (2): 525—529. PMID 30547273. S2CID 56148131. doi:10.1007/s00415-018-9155-6.

semanticscholar.org

api.semanticscholar.org

Nolan, D.; Carlson, M. (јун 2016). „Whole Exome Sequencing in Pediatric Neurology Patients: Clinical Implications and Estimated Cost Analysis”. Journal of Child Neurology. 31 (7): 887—94. PMID 26863999. S2CID 206552341. doi:10.1177/0883073815627880.
Strupp, Michael; Bayer, Otmar; Feil, Katharina; Straube, Andreas (2019). „Prophylactic treatment of migraine with and without aura with acetyl-dl-leucine: A case series”. Journal of Neurology. 266 (2): 525—529. PMID 30547273. S2CID 56148131. doi:10.1007/s00415-018-9155-6.

web.archive.org

„INTRABIO RECEIVES FDA RARE PEDIATRIC DISEASE DESIGNATION FOR IB1000S FOR GM2 GANGLIOSIDOSES | IntraBio” (на језику: енглески). 2018-10-01. Архивирано из оригинала 01. 08. 2019. г. Приступљено 2022-02-28.